Price (delayed)
$0.0001
Market cap
$2,802
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.32
Enterprise value
-$1.41M
novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability
There are no recent dividends present for NOVNQ.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.